Asarfi Hospital Limited has delivered robust financial performance for the quarter ended 31st December 2025, showcasing significant growth across key operational and profitability metrics. The Dhanbad-based healthcare provider announced its Q3FY26 results following a Board meeting held on 9th February 2026, with the company filing its regulatory disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

The company's standalone financial results reveal impressive year-on-year growth, with revenue from operations reaching ₹4,605.87 lakhs in Q3FY26 compared to ₹3,289.01 lakhs in the corresponding quarter of the previous year. Net profit after tax showed even stronger performance, climbing to ₹548.29 lakhs from ₹271.93 lakhs in Q3FY25.

Operational Excellence and Margin Expansion

The company demonstrated strong operational momentum with EBITDA margin reaching 22% and PAT margin at 12% for Q3FY26. The growth was driven by higher patient volumes, improved Average Revenue Per Occupied Bed (ARPOB), and enhanced case mix across both healthcare units. IPD revenue grew 42% year-on-year while OPD revenue increased 37%, supported by rising patient volumes and higher realizations.

Nine-Month Performance

The nine-month period ended 31st December 2025 demonstrated sustained growth trajectory, with revenue from operations increasing 46.04% to ₹12,656.94 lakhs compared to ₹8,667.37 lakhs in the corresponding period of FY25. Net profit after tax for the nine-month period reached ₹1,298.34 lakhs, representing an 81.57% increase from ₹715.10 lakhs in the previous year.

Specialty-Led Growth Strategy

The company's growth was driven by high-acuity segments including Cardiology and Neurosciences in the Super-Specialty unit, and Head & Neck and Haemato Oncology in the Cancer unit. This specialty-led approach has improved the overall revenue mix and complexity of care, contributing to enhanced profitability metrics. The company operates as a leading healthcare provider with a 20-year track record, running two hospitals across super-specialty and oncology care.

Balance Sheet Strength and Regulatory Compliance

The company's balance sheet as at 31st December 2025 reflects strengthened financial position with total assets increasing to ₹18,555.12 lakhs from ₹16,430.57 lakhs as at 31st March 2025. Cash and cash equivalents showed substantial improvement, rising to ₹1,701.79 lakhs from ₹131.56 lakhs, enhancing liquidity position. The financial results were audited by M/s R. K. Thakkar & Co., Chartered Accountants, who issued unmodified audit opinions on both standalone and consolidated financial statements.

Asarfi Hospital Limited has reported strong financial performance for its recent quarter, along with outlining ambitious expansion plans. The company's Board of Directors approved the results at a recent meeting.

Financial Results

Asarfi Hospital achieved consolidated revenue of ₹80.60 crores, marking a substantial 50% year-on-year growth. The company's Profit After Tax (PAT) rose by 70% to ₹7.32 crores. These results demonstrate robust financial health and operational efficiency, driven by doubled inpatient volumes and the successful launch of the Cancer Institute.

Vision 2027 and Expansion Plans

Asarfi Hospital has outlined its Vision 2027, setting ambitious targets for growth and expansion:

• Increase bed capacity to 500
• Achieve revenue of ₹200.00 crores
• Reach EBITDA margin of 25-27%

The company plans to achieve these goals through:

1. Expansion into Bihar and Eastern Uttar Pradesh
2. Introduction of advanced service lines, including bone marrow transplants
3. Vertical integration with education services

Current Operations

The company currently operates two hospitals in Dhanbad with a combined capacity of 330 beds.

Market Implications

The expansion plans and introduction of advanced services suggest that Asarfi Hospital is positioning itself for growth in the coming years. The focus on expanding into new geographical areas and introducing specialized services could potentially enhance the hospital's market position and patient base.

Corporate Structure

Asarfi Hospital Limited operates primarily in the hospital segment. The company has a subsidiary named Asarfi Educational Foundation, which aligns with its plans for vertical integration with education services.

The company's shares are listed on the BSE SME platform.